ID   OCI-Ly9
AC   CVCL_QW65
SY   OCI-LY9; OCI-Ly 9
DR   Wikidata; Q54931779
RX   PubMed=3567358;
RX   PubMed=8574164;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
RX   PubMed=3567358; DOI=10.1182/blood.V69.5.1307.1307;
RA   Tweeddale, Mary Elizabeth
RA   Lim, Bing
RA   Jamal, Nazir
RA   Robinson, Jean
RA   Zalcberg, John Raymond
RA   Lockwood, Gina
RA   Minden, Mark David
RA   Messner, Hans August
RT   "The presence of clonogenic cells in high-grade malignant lymphoma: a
RT   prognostic factor.";
RL   Blood 69:1307-1314(1987).
//
RX   PubMed=8574164; DOI=10.3109/10428199509059672;
RA   Chang, Hong
RA   Blondal, John A.
RA   Benchimol, Sam
RA   Minden, Mark David
RA   Messner, Hans August
RT   "p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's
RT   lymphoma cell lines.";
RL   Leuk. Lymphoma 19:165-171(1995).
//